학술논문
Outcomes to first-line pembrolizumab in patients with non-small-cell lung cancer and very high PD-L1 expression
Document Type
Article
Author
Source
In Annals of Oncology October 2019 30(10):1653-1659
Subject
Language
ISSN
0923-7534